28004277|t|Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
28004277|a|The activation of the highly conserved unfolded protein response (UPR) is prominent in the pathogenesis of the most prevalent neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), which are classically characterized by an accumulation of aggregated or misfolded proteins. This activation is orchestrated by three endoplasmic reticulum (ER) stress sensors: PERK, ATF6 and IRE1. These sensors transduce signals that induce the expression of the UPR gene programme. Here, we first identified an early activator of the UPR and investigated the role of a chronically activated UPR in the pathogenesis of X-linked adrenoleukodystrophy (X-ALD), a neurometabolic disorder that is caused by ABCD1 malfunction; ABCD1 transports very long-chain fatty acids (VLCFA) into peroxisomes. The disease manifests as inflammatory demyelination in the brain or and/or degeneration of corticospinal tracts, thereby resulting in spastic paraplegia, with the accumulation of intracellular VLCFA instead of protein aggregates. Using X-ALD mouse model (Abcd1 - and Abcd1 - /Abcd2 -/- mice) and X-ALD patient's fibroblasts and brain samples, we discovered an early engagement of the UPR. The response was characterized by the activation of the PERK and ATF6 pathways, but not the IRE1 pathway, showing a difference from the models of AD, PD or ALS. Inhibition of PERK leads to the disruption of homeostasis and increased apoptosis during ER stress induced in X-ALD fibroblasts. Redox imbalance appears to be the mechanism that initiates ER stress in X-ALD. Most importantly, we demonstrated that the bile acid tauroursodeoxycholate (TUDCA) abolishes UPR activation, which results in improvement of axonal degeneration and its associated locomotor impairment in Abcd1 - /Abcd2 -/- mice. Altogether, our preclinical data provide evidence for establishing the UPR as a key drug target in the pathogenesis cascade. Our study also highlights the potential role of TUDCA as a treatment for X-ALD and other axonopathies in which similar molecular mediators are implicated.
28004277	0	30	Tauroursodeoxycholic bile acid	Chemical	-
28004277	39	58	axonal degeneration	Disease	MESH:D009410
28004277	106	135	X-linked adrenoleukodystrophy	Disease	MESH:D000326
28004277	263	290	neurodegenerative disorders	Disease	MESH:D019636
28004277	300	319	Alzheimer's disease	Disease	MESH:D000544
28004277	321	323	AD	Disease	MESH:D000544
28004277	326	345	Parkinson's disease	Disease	MESH:D010300
28004277	347	349	PD	Disease	MESH:D010300
28004277	355	384	amyotrophic lateral sclerosis	Disease	MESH:D000690
28004277	386	389	ALS	Disease	MESH:D000690
28004277	568	572	PERK	Gene	13666
28004277	574	578	ATF6	Gene	226641
28004277	583	587	IRE1	Gene	26918
28004277	811	840	X-linked adrenoleukodystrophy	Disease	MESH:D000326
28004277	842	847	X-ALD	Disease	MESH:D000326
28004277	852	875	neurometabolic disorder	Disease	MESH:D009358
28004277	894	899	ABCD1	Gene	11666
28004277	913	918	ABCD1	Gene	11666
28004277	935	957	long-chain fatty acids	Chemical	-
28004277	959	964	VLCFA	Chemical	MESH:C017364
28004277	1009	1048	inflammatory demyelination in the brain	Disease	MESH:D020277
28004277	1059	1095	degeneration of corticospinal tracts	Disease	MESH:D009410
28004277	1118	1136	spastic paraplegia	Disease	MESH:D010264
28004277	1177	1182	VLCFA	Chemical	MESH:C017364
28004277	1220	1225	X-ALD	Disease	MESH:D000326
28004277	1226	1231	mouse	Species	10090
28004277	1239	1244	Abcd1	Gene	11666
28004277	1251	1256	Abcd1	Gene	11666
28004277	1260	1265	Abcd2	Gene	26874
28004277	1270	1274	mice	Species	10090
28004277	1280	1285	X-ALD	Disease	MESH:D000326
28004277	1286	1293	patient	Species	9606
28004277	1429	1433	PERK	Gene	13666
28004277	1438	1442	ATF6	Gene	226641
28004277	1465	1469	IRE1	Gene	26918
28004277	1519	1521	AD	Disease	MESH:D000544
28004277	1523	1525	PD	Disease	MESH:D010300
28004277	1529	1532	ALS	Disease	MESH:D000690
28004277	1548	1552	PERK	Gene	13666
28004277	1644	1649	X-ALD	Disease	MESH:D000326
28004277	1735	1740	X-ALD	Disease	MESH:D000326
28004277	1785	1794	bile acid	Chemical	MESH:D001647
28004277	1795	1816	tauroursodeoxycholate	Chemical	MESH:C031655
28004277	1818	1823	TUDCA	Chemical	MESH:C031655
28004277	1883	1902	axonal degeneration	Disease	MESH:D009410
28004277	1922	1942	locomotor impairment	Disease	MESH:D001523
28004277	1946	1951	Abcd1	Gene	11666
28004277	1955	1960	Abcd2	Gene	26874
28004277	1965	1969	mice	Species	10090
28004277	2144	2149	TUDCA	Chemical	MESH:C031655
28004277	2169	2174	X-ALD	Disease	MESH:D000326
28004277	2185	2197	axonopathies	Disease	MESH:D016472
28004277	Negative_Correlation	MESH:D001647	MESH:D009410
28004277	Positive_Correlation	MESH:C017364	MESH:D020277
28004277	Association	MESH:D000326	13666
28004277	Negative_Correlation	MESH:C031655	MESH:D016472
28004277	Negative_Correlation	MESH:C031655	MESH:D009410
28004277	Association	MESH:C017364	11666
28004277	Negative_Correlation	MESH:C031655	MESH:D001523
28004277	Association	MESH:D000326	11666
28004277	Positive_Correlation	MESH:C017364	MESH:D010264
28004277	Negative_Correlation	MESH:C031655	MESH:D000326
28004277	Negative_Correlation	MESH:D001647	MESH:D001523

